Home

Sun Pharmaceuticals Industries Ltd Quarterly Result

Image

Sun Pharmaceuticals Industries Ltd

NSE: SUNPHARMA

Net Profit - Last Quarter

₹ 3030.67 Cr.

Last updated on: Jan 22, 2025

Sun Pharmaceuticals Industries Ltd Quarterly Results Key Highlights

  • The revenue of Sun Pharmaceuticals Industries Ltd for the Sep '24 is ₹ 13645 crore as compare to the Jun '24 revenue of ₹ 13185 crore.
  • This represent the growth of 3.49%a1# The ebitda of Sun Pharmaceuticals Industries Ltd for the Sep '24 is ₹ 4292 crore as compare to the Jun '24 ebitda of ₹ 4140 crore.
  • This represent the growth of 3.69%a1# The net profit of Sun Pharmaceuticals Industries Ltd for the Sep '24 is ₹ 3030 crore as compare to the Jun '24 net profit of ₹ 2871 crore.
  • This represent the growth of 5.55%a1#.

Sun Pharmaceuticals Industries Ltd Quarterly Results Analysis

Market Price of Sun Pharmaceuticals Industries Ltd

1M

1Y

3Y

5Y

Monitoring Sun Pharmaceuticals Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Jan 20251798
21 Jan 20251761.8
20 Jan 20251775.9
17 Jan 20251786.15
16 Jan 20251763.5
15 Jan 20251756.85
14 Jan 20251768.75
13 Jan 20251746.05
10 Jan 20251786.05
09 Jan 20251826.1

Historical Revenue of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical EBITDA of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical Net Profit of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Sun Pharmaceuticals Industries Ltd News Hub

Sun Pharmaceuticals Industries Ltd spurts 0.31%, up for fifth straight session

Sun Pharmaceuticals Industries Ltd gained for a fifth straight session today. The stock is quoting a

Read more

20 Aug 2024

Sun Pharmaceutical to invest USD 15 mn in Pharmazz Inc.

Sun Pharmaceutical Industries has entered into an agreement with Pharmazz Inc. Delaware US, pursuant

Read more

14 Aug 2024

Sun Pharma Q1 PAT climbs 40% YoY to Rs 2,835 cr

Profit before tax was at Rs 3,423.5 crore in Q1 FY25, registering a growth of 37.98% on YoY basis. D

Read more

01 Aug 2024

Sun Pharmaceuticals Industries consolidated net profit rises 40.20% in the June 2024 quarter

Net profit of Sun Pharmaceuticals Industries rose 40.20% to Rs 2835.62 crore in the quarter ended Ju

Read more

01 Aug 2024

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

July 2024

PPT

May 2024

Transcript

Mar 2024

PPT

Feb 2024

Transcript

Jan 2024

PPT

Nov 2023

Transcript

Sep 2023

PPT

May 2023

Transcript

Apr 2023

PPT

Nov 2022

Transcript

Sep 2022

PPT

Aug 2022

Transcript

June 2022

Transcript

Mar 2022

PPT

Feb 2022

Transcript

Nov 2021

Transcript

Aug 2021

Transcript

June 2021

Transcript

Jan 2021

Transcript

FAQs for Quarterly Results of Sun Pharmaceuticals Industries Ltd

What key financial metrics are included in Sun Pharmaceuticals Industries Ltd's quarterly results?

Key financial metrics in Sun Pharmaceuticals Industries Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Sun Pharmaceuticals Industries Ltd announce its quarterly results?

Sun Pharmaceuticals Industries Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Sun Pharmaceuticals Industries Ltd's quarterly performance impact its stock price?

Sun Pharmaceuticals Industries Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Sun Pharmaceuticals Industries Ltd's quarterly results on dividends?

The impact of Sun Pharmaceuticals Industries Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Sun Pharmaceuticals Industries Ltd's quarterly results?

Yes, Sun Pharmaceuticals Industries Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions